nf023 has been researched along with Plasmodium falciparum Malaria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esser, D; Kassack, MU; Lima, LM; Marques, AF; Rosenthal, PJ | 1 |
| Miller, ME; Nelson, SW; Parrott, EE; Singh, R | 1 |
2 other study(ies) available for nf023 and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Falcipain-2 inhibition by suramin and suramin analogues.
Topics: Antimalarials; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Malaria, Falciparum; Molecular Docking Simulation; Plasmodium falciparum; Suramin | 2013 |
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
Topics: Antimalarials; Apicoplasts; Chloroplasts; DNA; DNA-Directed DNA Polymerase; Drug Discovery; Exonucleases; Humans; Kinetics; Malaria, Falciparum; Mitochondria; Multienzyme Complexes; Nucleic Acid Synthesis Inhibitors; Peptide Library; Plasmodium falciparum; Protozoan Proteins; Spectrometry, Fluorescence | 2014 |